Immune-Onc Therapeutics
PrivateLast Round
Series B
Extension
Jan 5, 2023
Total Funding Raised
$140.14M
Company Overview
Immune-Onc Therapeutics is a biopharmaceutical company focused on developing innovative therapies in immunology and oncology that target myeloid cells to combat immune suppression in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immune-Onc Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Immune-Onc Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 5, 2023 | ||||
| Series B | Mar 30, 2021 | ||||
| Grant | Aug 4, 2020 | ||||
| Series B | Sep 18, 2018 | ||||
| Series A | Sep 1, 2016 |
Key People
Founding team and executive leadership
Immune-Onc Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| StartX | Series B |
| Triwise Capital | Series B Extension |
| Northern Light Venture Capital | Series B |
| Stanford-StartX Fund | Series B |
| Oceanpine Capital | Series B |
| 中南创投基金 | Series B |
Immune-Onc Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immune-Onc Therapeutics's valuation, stock price, and market status.
